Healthcare Business Review
About Us Conference Advertise With Us
  • APAC
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Sections
    Business Process Outsourcing
    Compliance & Risk Management
    Consulting Service
    Facility Management Services
    Financial Services
    Healthcare Education
    healthcare Insurance
    Healthcare Marketing
    Healthcare Outsourcing
    Healthcare Procurement
    Healthcare Staffing
    Medical Billing
    Medical Staff Training and Development
    Medical Transportation
    Nurse Staffing
    Plastic Surgery
    Regenerative Medicine
    Therapy Services 
    Business Process Outsourcing
    Compliance & Risk Management
    Consulting Service
    Facility Management Services
    Financial Services
    Healthcare Education
    healthcare Insurance
    Healthcare Marketing
    Healthcare Outsourcing
    Healthcare Procurement
    Healthcare Staffing
    Medical Billing
    Medical Staff Training and Development
    Medical Transportation
    Nurse Staffing
    Plastic Surgery
    Regenerative Medicine
    Therapy Services 
  • Leadership Perspectives
  • Insights
  • News
  • CXO Awards
×
#

Healthcare Business Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review

Subscribe

loading

EML has been recognized by Healthcare Business Review Magazine as the exclusive recipient of “Top Pharmaceutical Marketing Agency in Latin America 2025,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Healthcare Business Review research and editorial team based on insights from an interview with Luis Fernando Garzón Monzón, MD - CEO.

EML

Turning Complex Science into Clear Brand Strategies
EML

Luis Fernando Garzón Monzón, EML | Healthcare Business Review | Top Pharmaceutical Marketing Agency in Latin AmericaLuis Fernando Garzón Monzón, MD - CEO
EML empowers pharmaceutical brands to create authentic experiences and communicate effectively with professionals, patients and stakeholders. It builds connections by combining 360° campaigns and experiential activations to advance the sector’s evolution.

In 2024 alone, EML has partnered with more than 90 pharmaceutical companies and 300 clients across 13 countries. Campaigns are delivered in multiple languages and adapted to local cultures, shaping how health information is shared, understood and acted upon. Clear and impactful communication turns knowledge into strategies that build trust and improve health outcomes.

“More than a marketing agency, we see ourselves as a strategic partner in the evolution of the health industry,” says Eliana Pedraza, Innovation Manager.

Strategic partnership matters as the healthcare industry faces increasing complexity. Strict regulations and evolving digital channels demand communication that reaches diverse audiences without losing scientific accuracy. EML meets this challenge by designing campaigns that are compliant and capable of sparking connections that inspire meaningful action and deliver measurable results.

“Personalization drives every engagement. Each project begins with a rigorous discovery process that clarifies client needs, brand identity, and market conditions. Every initiative aligns with the client’s goals while addressing the distinct context of the brand,” says Juan Camilo Martínez, Healthcare Strategy Director.

Technology integration amplifies the agency’s impact. EML was among the first to incorporate platforms like Veeva and IQVIA into pharmaceutical marketing strategies. These tools allow campaigns to deliver modular content tailored to specific audiences. They also support ethical engagement with physicians, helping clients build trust while optimizing marketing investments. The platforms help EML deliver timely, relevant information that supports clinical decisions and boosts campaign results.

Innovation extends into artificial intelligence and omnichannel engagement, where campaigns are designed to be adaptive, interactive, and data-driven. AI personalization delivers content relevant to each audience while multichannel systems monitor and refine engagement in real time. This combination expands brand reach and transforms communications into sustained, value-driven experiences that deepen trust.
  • More than a marketing agency, we see ourselves as a strategic partner in the evolution of the health industry.


“Underpinning EML’s approach is a team of specialists who understand medicine and marketing. Scientific writers, designers, developers, and strategists collaborate to craft experiences that resonate across cultural and linguistic boundaries. A dedicated team of healthcare writers validates every message with evidence-based references, ensuring precision and credibility,” says Luis Fernando Garzón Monzón, MD - CEO.

A culture of accountability matches this expertise. EML embeds ethics and scientific rigor into every decision, from concept development to final delivery. Grounded in credibility, clients earn recognition as responsible partners to professionals and patients, securing brand durability and continuous compliance.

“The foundation of credibility naturally translates into breakthrough outcomes. Working with the Colombian Red Cross, EML developed the award-winning ‘Explosive Toys’ campaign to raise awareness about the dangers of fireworks. The campaign turned everyday toys into vivid symbols of risk and reduced national fireworks injuries by 18.8 percent, showing how strong communication can drive real social change,” says Yury Lesnikov, Creative Director.

EML’s vision reaches far beyond producing individual campaigns. It plans to add advanced data-driven platforms that help measure results and guide smarter decisions. The aim is to expand into new international markets, bringing its expertise to a broader audience.

Its achievements have already earned recognition. Prestigious ASPID awards and professional certifications highlight the consistent quality that defines the work.

EML stays focused on keeping healthcare brands active and relevant in a changing market. Positioned as a trusted partner, it adapts with the industry while staying committed to building lasting brands focused on saving lives.

Top Pharmaceutical Marketing Agency in Latin America 2025
Current Issue

Company :EML

Management

Luis Fernando Garzón Monzón, MD - CEO
Eliana Pedraza, Innovation Manager, Juan Camilo Martínez, Healthcare Strategy Director, Yury Lesnikov, Creative Director

Thank you for Subscribing to Healthcare Business Review Weekly Brief

Copyright © 2026 Healthcare Business Review. All rights reserved. |  Subscribe |  Sitemap |  About us |  Newsletter |  Feedback Policy |  Editorial Policy follow on linkedin
CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.healthcarebusinessreviewapac.com/eml